Advancing gene editing by engineering miniature CRISPR-Cas Un1Cas12f1

被引：0
|
作者：
Tang, Weimin [1 ,2 ]
机构：
[1] Harvard Med Sch, Boston Childrens Hosp, Lab Biomat & Drug Delivery, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston Childrens Hosp, Dept Med Crit Care, Boston, MA 02115 USA
来源：
MOLECULAR THERAPY NUCLEIC ACIDS | 2024年 / 35卷 / 03期
关键词：
D O I：
10.1016/j.omtn.2024.102302
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Cpf1 CRISPR-Cas protein expands genome-editing tools
    Fagerlund, Robert D.
    Staals, Raymond H. J.
    Fineran, Peter C.
    GENOME BIOLOGY, 2015, 16
  • [42] The Cpf1 CRISPR-Cas protein expands genome-editing tools
    Robert D. Fagerlund
    Raymond H. J. Staals
    Peter C. Fineran
    Genome Biology, 16
  • [43] GENERATION OF IL1β-RESISTANT CHONDROCYTES USING CRISPR-CAS GENOME EDITING
    Karlsen, T. A.
    Pernas, P. F.
    Staerk, J.
    Caglayan, S.
    Brinchmann, J. E.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S325 - S325
  • [44] Characterization and Engineering of a Novel Miniature Eubacterium siraeum CRISPR-Cas12f System
    Wang, Yannan
    Wang, Yujue
    Tang, Na
    Wang, Zhipeng
    Pan, Deng
    Ji, Quanjiang
    ACS SYNTHETIC BIOLOGY, 2024, 13 (07): : 2115 - 2127
  • [45] FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology
    Grant, Evita V.
    FOOD AND DRUG LAW JOURNAL, 2016, 71 (04) : 608 - 633
  • [46] Engineering salt-tolerant Cas12f1 variants for gene-editing applications
    Daskalakis, Vangelis
    Papapetros, Spyridon
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (14): : 7421 - 7431
  • [47] CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells
    van Essen, Max
    Riepsaame, Joey
    Jacob, John
    CRISPR JOURNAL, 2021, 4 (05): : 634 - 655
  • [48] Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems
    Brokso, Amalie Dyrelund
    Bendixen, Louise
    Famme, Simon
    Mikkelsen, Kasper
    Jensen, Trine Ilso
    Bak, Rasmus O.
    MOLECULAR THERAPY, 2025, 33 (01) : 71 - 89
  • [49] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Miaoxian Guo
    Hongyu Chen
    Shuting Dong
    Zheng Zhang
    Hongmei Luo
    Chinese Medicine, 17
  • [50] CRISPR-Cas gene editing technology and its application prospect in medicinal plants
    Guo, Miaoxian
    Chen, Hongyu
    Dong, Shuting
    Zhang, Zheng
    Luo, Hongmei
    CHINESE MEDICINE, 2022, 17 (01)
12345